Global Osteoarthritis Pain Drugs Competitive Landscape Professional Research Report 2026

According to DIResearch＇s in-depth investigation and research, the global Osteoarthritis Pain Drugs market size will reach 12,276 Million USD in 2026 and is projected to reach 18,144 Million USD by 2033, with a CAGR of 5.74% (2026-2033). Notably, the China Osteoarthritis Pain Drugs market has changed rapidly in the past few years. By 2026, China＇s market size is expected to be Million USD, representing approximately % of the global market share.

Research Summary

Osteoarthritis pain drugs are medications used to manage the pain and symptoms associated with osteoarthritis, a degenerative joint disease that causes joint pain, stiffness, and reduced mobility. These drugs include nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen and naproxen, which help reduce inflammation and pain; acetaminophen, which is used for pain relief but has less anti-inflammatory action; and opioid analgesics, like tramadol, prescribed for more severe pain cases. Topical creams and gels containing capsaicin, salicylates, or NSAIDs can also provide localized relief. Additionally, disease-modifying osteoarthritis drugs (DMOADs), such as hyaluronic acid injections, are used to improve joint function and slow disease progression. The choice of osteoarthritis pain medication depends on factors like the severity of pain, individual health considerations, and the potential for side effects.

The major global suppliers of Osteoarthritis Pain Drugs include Pfizer, Bayer, SK Chemicals, GSK, Sanofi, Crystal Genomics, Johnson & Johnson, Sino Biopharmaceutical, Haohai Biological, Freda, Zhejiang Chengyi Pharmaceutical, Bright Future, Jingfeng Pharmaceutical, Chugai Pharmaceutical, Mikasa Seiyaku, Taisho Pharmaceutical, Seikagaku Corporation, GlaxoSmithKline, Eli Lilly, Novartis, Horizon Pharma, Abbott, Mylan, TEVA, Daiichi Sankyo, Almatica Pharma, Tide Pharmaceutical, Astellas Pharma, Iroko Pharmaceuticals, Hengrui Pharmaceutical, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.

This report studies the market size, price trends and future development prospects of Osteoarthritis Pain Drugs. Focus on analysing the market share, product portfolio, prices, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Osteoarthritis Pain Drugs market. The report data covers historical data from 2021 to 2025, based year in 2026 and forecast data from 2027 to 2033.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Osteoarthritis Pain Drugs market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Osteoarthritis Pain Drugs industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.  

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Suppliers of Osteoarthritis Pain Drugs Include:

Pfizer

Bayer

SK Chemicals

GSK

Sanofi

Crystal Genomics

Johnson & Johnson

Sino Biopharmaceutical

Haohai Biological

Freda

Zhejiang Chengyi Pharmaceutical

Bright Future

Jingfeng Pharmaceutical

Chugai Pharmaceutical

Mikasa Seiyaku

Taisho Pharmaceutical

Seikagaku Corporation

GlaxoSmithKline

Eli Lilly

Novartis

Horizon Pharma

Abbott

Mylan

TEVA

Daiichi Sankyo

Almatica Pharma

Tide Pharmaceutical

Astellas Pharma

Iroko Pharmaceuticals

Hengrui Pharmaceutical

Osteoarthritis Pain Drugs Product Segment Include:

Oral Drugs

Injection Drugs

Topical Drugs

Osteoarthritis Pain Drugs Product Application Include:

Medical Care

Personal Care

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Osteoarthritis Pain Drugs Industry PESTEL Analysis

Chapter 3: Global Osteoarthritis Pain Drugs Industry Porter’s Five Forces Analysis

Chapter 4: Global Osteoarthritis Pain Drugs Major Regional Market Size and Forecast Analysis

Chapter 5: Global Osteoarthritis Pain Drugs Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Passenger Osteoarthritis Pain Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Osteoarthritis Pain Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Osteoarthritis Pain Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Osteoarthritis Pain Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Osteoarthritis Pain Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Osteoarthritis Pain Drugs Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Osteoarthritis Pain Drugs Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table 1： Global Osteoarthritis Pain Drugs Market Size Growth Rate by Type, 2025 VS 2026 VS 2033 (US$ Million)

Table 2： Global Osteoarthritis Pain Drugs Market Size Growth Rate by Application, 2025 VS 2026 VS 2033 (US$ Million)

Table 3： Osteoarthritis Pain Drugs Industry Development Status

Table 4： Osteoarthritis Pain Drugs Industry Development Trends

Table 5： Global Osteoarthritis Pain Drugs Market Size by Region in US$ Million: 2025 VS 2026 VS 2033

Table 6： Global Osteoarthritis Pain Drugs Revenue by Region (2021-2026) & (US$ Million)

Table 7： Global Osteoarthritis Pain Drugs Revenue Market Share by Region (2021-2026)

Table 8： Global Osteoarthritis Pain Drugs Revenue Forecast by Region (2027-2033) & (US$ Million)

Table 9： Global Osteoarthritis Pain Drugs Revenue Market Share Forecast by Region (2027-2033)

Table 10： Global Osteoarthritis Pain Drugs Revenue Analysis by Type (2021-2026) & (US$ Million)

Table 11： Global Osteoarthritis Pain Drugs Revenue Analysis Forecast by Type (2027-2033) & (US$ Million)

Table 12： Global Osteoarthritis Pain Drugs Revenue Analysis by Application (2021-2026) & (US$ Million)

Table 13： Global Osteoarthritis Pain Drugs Revenue Analysis Forecast by Application (2027-2033) & (US$ Million)

Table 14： Key Osteoarthritis Pain Drugs Players in North America

Table 15： North America Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (US$ Million)

Table 16： North America Osteoarthritis Pain Drugs Revenue by Type (2027-2033) & (US$ Million)

Table 17： North America Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (US$ Million)

Table 18： North America Osteoarthritis Pain Drugs Revenue by Application (2027-2033) & (US$ Million)

Table 19： North America Osteoarthritis Pain Drugs Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 20： North America Osteoarthritis Pain Drugs Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 21： Key Osteoarthritis Pain Drugs Players in Europe

Table 22： Europe Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (US$ Million)

Table 23： Europe Osteoarthritis Pain Drugs Revenue by Type (2027-2033) & (US$ Million)

Table 24： Europe Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (US$ Million)

Table 25： Europe Osteoarthritis Pain Drugs Revenue by Application (2027-2033) & (US$ Million)

Table 26： Europe Osteoarthritis Pain Drugs Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 27： Europe Osteoarthritis Pain Drugs Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 28： Key Osteoarthritis Pain Drugs Players in China

Table 29： China Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (US$ Million)

Table 30： China Osteoarthritis Pain Drugs Revenue by Type (2027-2033) & (US$ Million)

Table 31： China Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (US$ Million)

Table 32： China Osteoarthritis Pain Drugs Revenue by Application (2027-2033) & (US$ Million)

Table 33： Key Osteoarthritis Pain Drugs Players in APAC (excl. China)

Table 34： APAC (excl. China) Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (US$ Million)

Table 35： APAC (excl. China) Osteoarthritis Pain Drugs Revenue by Type (2027-2033) & (US$ Million)

Table 36： APAC (excl. China) Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (US$ Million)

Table 37： APAC (excl. China) Osteoarthritis Pain Drugs Revenue by Application (2027-2033) & (US$ Million)

Table 38： APAC (excl. China) Osteoarthritis Pain Drugs Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 39： APAC (excl. China) Osteoarthritis Pain Drugs Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 40： Key Osteoarthritis Pain Drugs Players in Latin America

Table 41： Latin America Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (US$ Million)

Table 42： Latin America Osteoarthritis Pain Drugs Revenue by Type (2027-2033) & (US$ Million)

Table 43： Latin America Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (US$ Million)

Table 44： Latin America Osteoarthritis Pain Drugs Revenue by Application (2027-2033) & (US$ Million)

Table 45： Latin America Osteoarthritis Pain Drugs Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 46： Latin America Osteoarthritis Pain Drugs Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 47： Key Osteoarthritis Pain Drugs Players in Middle East & Africa

Table 48： Middle East & Africa Osteoarthritis Pain Drugs Revenue by Type (2021-2026) & (US$ Million)

Table 49： Middle East & Africa Osteoarthritis Pain Drugs Revenue by Type (2027-2033) & (US$ Million)

Table 50： Middle East & Africa Osteoarthritis Pain Drugs Revenue by Application (2021-2026) & (US$ Million)

Table 51： Middle East & Africa Osteoarthritis Pain Drugs Revenue by Application (2027-2033) & (US$ Million)

Table 52： Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Size by Country (2021-2026) & (US$ Million)

Table 53： Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Size by Country (2027-2033) & (US$ Million)

Table 54： Global Osteoarthritis Pain Drugs Market Revenue by Key Suppliers (2021-2026) & (US$ Million)

Table 55： Global Osteoarthritis Pain Drugs Revenue Market Share by Key Suppliers (2021-2026)

Table 56： Global Key Suppliers Headquarter Location and Key Area Sales

Table 57： Market Mergers & Acquisitions, Expansion

Table 58： Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 59： Pfizer Osteoarthritis Pain Drugs Product Portfolio

Table 60： Pfizer Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 61： Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 62： Bayer Osteoarthritis Pain Drugs Product Portfolio

Table 63： Bayer Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 64： SK Chemicals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 65： SK Chemicals Osteoarthritis Pain Drugs Product Portfolio

Table 66： SK Chemicals Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 67： GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 68： GSK Osteoarthritis Pain Drugs Product Portfolio

Table 69： GSK Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 70： Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 71： Sanofi Osteoarthritis Pain Drugs Product Portfolio

Table 72： Sanofi Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 73： Crystal Genomics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 74： Crystal Genomics Osteoarthritis Pain Drugs Product Portfolio

Table 75： Crystal Genomics Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 76： Johnson & Johnson Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 77： Johnson & Johnson Osteoarthritis Pain Drugs Product Portfolio

Table 78： Johnson & Johnson Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 79： Sino Biopharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 80： Sino Biopharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 81： Sino Biopharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 82： Haohai Biological Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 83： Haohai Biological Osteoarthritis Pain Drugs Product Portfolio

Table 84： Haohai Biological Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 85： Freda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 86： Freda Osteoarthritis Pain Drugs Product Portfolio

Table 87： Freda Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 88： Zhejiang Chengyi Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 89： Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 90： Zhejiang Chengyi Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 91： Bright Future Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 92： Bright Future Osteoarthritis Pain Drugs Product Portfolio

Table 93： Bright Future Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 94： Jingfeng Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 95： Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 96： Jingfeng Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 97： Chugai Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 98： Chugai Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 99： Chugai Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 100： Mikasa Seiyaku Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 101： Mikasa Seiyaku Osteoarthritis Pain Drugs Product Portfolio

Table 102： Mikasa Seiyaku Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 103： Taisho Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 104： Taisho Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 105： Taisho Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 106： Seikagaku Corporation Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 107： Seikagaku Corporation Osteoarthritis Pain Drugs Product Portfolio

Table 108： Seikagaku Corporation Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 109： GlaxoSmithKline Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 110： GlaxoSmithKline Osteoarthritis Pain Drugs Product Portfolio

Table 111： GlaxoSmithKline Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 112： Eli Lilly Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 113： Eli Lilly Osteoarthritis Pain Drugs Product Portfolio

Table 114： Eli Lilly Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 115： Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 116： Novartis Osteoarthritis Pain Drugs Product Portfolio

Table 117： Novartis Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 118： Horizon Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 119： Horizon Pharma Osteoarthritis Pain Drugs Product Portfolio

Table 120： Horizon Pharma Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 121： Abbott Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 122： Abbott Osteoarthritis Pain Drugs Product Portfolio

Table 123： Abbott Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 124： Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 125： Mylan Osteoarthritis Pain Drugs Product Portfolio

Table 126： Mylan Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 127： TEVA Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 128： TEVA Osteoarthritis Pain Drugs Product Portfolio

Table 129： TEVA Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 130： Daiichi Sankyo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 131： Daiichi Sankyo Osteoarthritis Pain Drugs Product Portfolio

Table 132： Daiichi Sankyo Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 133： Almatica Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 134： Almatica Pharma Osteoarthritis Pain Drugs Product Portfolio

Table 135： Almatica Pharma Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 136： Tide Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 137： Tide Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 138： Tide Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 139： Astellas Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 140： Astellas Pharma Osteoarthritis Pain Drugs Product Portfolio

Table 141： Astellas Pharma Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 142： Iroko Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 143： Iroko Pharmaceuticals Osteoarthritis Pain Drugs Product Portfolio

Table 144： Iroko Pharmaceuticals Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 145： Hengrui Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

Table 146： Hengrui Pharmaceutical Osteoarthritis Pain Drugs Product Portfolio

Table 147： Hengrui Pharmaceutical Osteoarthritis Pain Drugs Revenue (US$ Million), Gross Margin and Market Share (2021-2026)

Table 148： Osteoarthritis Pain Drugs Typical Customer List

Table 149： Osteoarthritis Pain Drugs Distributors List

Figure 1： Osteoarthritis Pain Drugs Product Pictures

Figure 2： Oral Drugs Picture Scope

Figure 3： Injection Drugs Picture Scope

Figure 4： Topical Drugs Picture Scope

Figure 5： Medical Care Picture Scope

Figure 6： Personal Care Picture Scope

Figure 7： Global Osteoarthritis Pain Drugs Market Size Analysis: 2025 VS 2026 VS 2033 (US$ Million)

Figure 8： Global Osteoarthritis Pain Drugs Market Revenue and Growth Rate Analysis: (2021-2033) & (US$ Million)

Figure 9： Global Osteoarthritis Pain Drugs Market Size by Region (2021-2033) & (US$ Million)

Figure 10： Global Osteoarthritis Pain Drugs Market Share Scenario by Region in Percentage: 2026 Versus 2033

Figure 11： North America Osteoarthritis Pain Drugs Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 12： North America Osteoarthritis Pain Drugs Market Share by Players in 2025

Figure 13： North America Osteoarthritis Pain Drugs Revenue Market Share by Type (2021-2033)

Figure 14： North America Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 15： US Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 16： Canada Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 17： Europe Osteoarthritis Pain Drugs Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 18： Europe Osteoarthritis Pain Drugs Market Share by Players in 2025

Figure 19： Europe Osteoarthritis Pain Drugs Revenue Market Share by Type (2021-2033)

Figure 20： Europe Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 21： Germany Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 22： France Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 23： United Kingdom Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 24： Italy Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 25： Spain Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 26： Benelux Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 27： China Osteoarthritis Pain Drugs Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 28： China Osteoarthritis Pain Drugs Market Share by Players in 2025

Figure 29： China Osteoarthritis Pain Drugs Revenue Market Share by Type (2021-2033)

Figure 30： China Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 31： APAC (excl. China) Osteoarthritis Pain Drugs Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 32： APAC (excl. China) Osteoarthritis Pain Drugs Market Share by Players in 2025

Figure 33： APAC (excl. China) Osteoarthritis Pain Drugs Revenue Market Share by Type (2021-2033)

Figure 34： APAC (excl. China) Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 35： Japan Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 36： South Korea Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 37： India Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 38： Australia Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 39： Southeast Asia Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 40： Latin America Osteoarthritis Pain Drugs Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 41： Latin America Osteoarthritis Pain Drugs Market Share by Players in 2025

Figure 42： Latin America Osteoarthritis Pain Drugs Revenue Market Share by Type (2021-2033)

Figure 43： Latin America Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 44： Mexico Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 45： Brazil Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 46： Middle East & Africa Osteoarthritis Pain Drugs Market Size and Growth Rate (2021-2033) & (US$ Million)

Figure 47： Middle East & Africa Osteoarthritis Pain Drugs Market Share by Players in 2025

Figure 48： Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Type (2021-2033)

Figure 49： Middle East & Africa Osteoarthritis Pain Drugs Revenue Market Share by Application (2021-2033)

Figure 50： Saudi Arabia Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 51： South Africa Osteoarthritis Pain Drugs Revenue (2021-2033) & (US$ Million)

Figure 52： Global Osteoarthritis Pain Drugs Revenue Market Share by Key Suppliers in 2025

Figure 53： Global Osteoarthritis Pain Drugs Industry Competition Landscape

Figure 54： Osteoarthritis Pain Drugs Industry Chain Analysis

Figure 55： Bottom-Up and Top-Down Research Methods

Figure 56： Key Interview Objectives

Figure 57： Data Cross Validation